Article history: Received: 2017 Background and Aims: The growing concern about bacterial strains resistant to antibiotics reveals the urgent need to discover and develop new types of bactericidal agents. Hence, the purpose of this study is to provide a new generation of microbial nano sized compounds for medical-industrial applications.
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